PeptideDB

UCB-J 2242957-52-2

UCB-J 2242957-52-2

CAS No.: 2242957-52-2

UCB-J is a positron emission tomography (PET) radioactive oligomer that is a ligand for synaptic vesicle protein 2A (SV2
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

UCB-J is a positron emission tomography (PET) radioactive oligomer that is a ligand for synaptic vesicle protein 2A (SV2A).

Physicochemical Properties


Molecular Formula C17H15F3N2O
Molecular Weight 320.31
Exact Mass 320.113
CAS # 2242957-52-2
PubChem CID 139953895
Appearance White to off-white solid powder
Density 1.329±0.06 g/cm3(Predicted)
Boiling Point 474.1±45.0 °C(Predicted)
LogP 2.3
Hydrogen Bond Donor Count 0
Hydrogen Bond Acceptor Count 5
Rotatable Bond Count 3
Heavy Atom Count 23
Complexity 424
Defined Atom Stereocenter Count 1
SMILES

CC1=C(C=CN=C1)CN2C[C@H](CC2=O)C3=CC(=C(C(=C3)F)F)F

InChi Key RFSDYRVOGWHOFT-ZDUSSCGKSA-N
InChi Code

InChI=1S/C17H15F3N2O/c1-10-7-21-3-2-11(10)8-22-9-13(6-16(22)23)12-4-14(18)17(20)15(19)5-12/h2-5,7,13H,6,8-9H2,1H3/t13-/m0/s1
Chemical Name

(4R)-1-[(3-methylpyridin-4-yl)methyl]-4-(3,4,5-trifluorophenyl)pyrrolidin-2-one
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture and light.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vivo In plasma, UCB-J shows a moderate rate of metabolism (39% ± 5% and 24% ± 3% parent remaining at 30 and 90 minutes) and a high free fraction (0.46 ± 0.02)[3]. In the monkey brain, UCB-J exhibits rapid kinetics and high uptake[3]. The entire brain SUV drops to the same amount as centrum semiovale when the animal is pretreated with UCB-J (150 μg/kg, iv), demonstrating the in vivo binding selectivity of [ 18F]7 to SV2A[4].
References

[1]. Discovery of heterocyclic nonacetamide synaptic vesicle protein 2A (SV2A) ligands with single-digit nanomolar potency: opening avenues towards the first SV2A positron emission tomography (PET) ligands. ChemMedChem. 2014 Apr;9(4):693-8.

[2]. Loss of Presynaptic Terminal Integrity in the Substantia Nigra in Early Parkinson's Disease. Mov Disord. 2020 Aug 7.

[3]. Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain. J Nucl Med. 2016 May;57(5):777-84.

[4]. Synthesis and Preclinical Evaluation of an 18 F-Labeled Synaptic Vesicle Glycoprotein 2A PET Imaging Probe: [ 18 F]SynVesT-2. ACS Chem Neurosci. 2020 Feb 19;11(4):592-603.


Solubility Data


Solubility (In Vitro) DMSO: 100 mg/mL (312.20 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (7.80 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (7.80 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 2.5 mg/mL (7.80 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 3.1220 mL 15.6099 mL 31.2198 mL
5 mM 0.6244 mL 3.1220 mL 6.2440 mL
10 mM 0.3122 mL 1.5610 mL 3.1220 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.